title: Recent concepts of autoimmune pancreatitis and IgG4-related disease.
abstract: Recent studies suggested the existence of two subtypes of autoimmune pancreatitis (AIP): type 1 related with IgG4 (lymphoplasmacytic sclerosing pancreatitis; LPSP) and type 2 related with a granulocytic epithelial lesion (idiopathic duct-centric chronic pancreatitis; IDCP). Apart from type 2 AIP, the pathological features of type 1 AIP with increased serum IgG4/IgE levels, abundant infiltration of IgG4+ plasmacytes and lymphocytes, fibrosis, and steroid responsiveness are suggestive of abnormal immunity such as allergy or autoimmunity. Moreover, the patients with type 1 AIP often have extrapancreatic lesions such as sclerosing cholangitis, sclerosing sialadenitis, or retroperitoneal fibrosis showing similar pathological features. Based on these findings, many synonyms have been proposed for these conditions, such as "multifocal idiopathic fibrosclerosis", "IgG4-related autoimmune disease", "IgG4-related sclerosing disease", "IgG4-related plasmacytic disease", and "IgG4-related multiorgan lymphoproliferative syndrome", all of which may refer to the same conditions. Therefore, the Japanese Research Committee for "Systemic IgG4-related Sclerosing Disease" proposed a disease concept and clinical diagnostic criteria based on the concept of multifocal fibrosclerosis in 2009, in which the term "IgG4-related disease" was appointed as a minimal consensus on these conditions. Although the significance of IgG4 in the development of "IgG4-related disease" remains unclear, we have proposed a hypothesis for the development of type 1 AIP, one of the IgG4-related disease. The concept and diagnostic criteria of "IgG4-related disease" will be changed in accordance with future studies.
authors.affiliation: The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Shinmachi, Hirakata, Osaka, Japan. okazaki@hirakata.kmu.ac.jp
authors.forename: Kazuichi
authors.initials: K
authors.lastname: Okazaki
authors.forename: Kazushige
authors.initials: K
authors.lastname: Uchida
authors.forename: Hideaki
authors.initials: H
authors.lastname: Miyoshi
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Ikeura
authors.forename: Makoto
authors.initials: M
authors.lastname: Takaoka
authors.forename: Akiyoshi
authors.initials: A
authors.lastname: Nishio
mesh_terms: D000465:Algorithms; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology; D015209:Cholangitis, Sclerosing; D002908:Chronic Disease; D003937:Diagnosis, Differential; D005349:Fibroins; D006098:Granulocytes / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology*; D007564:Japan; D008214:Lymphocytes / Q000276:immunology*; D010195:Pancreatitis / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D012598:Sclerosis; D012793:Sialadenitis
chemical_list: D007074:Immunoglobulin G; D005349:Fibroins